HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 5thDecember 2014
Summary The industry analysis specialist, has released its new report, “HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global HIV-Associated Diarrhea Therapeutics market. The report identifies the key trends shaping and driving the global HIV-Associated Diarrhea Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global HIV-Associated Diarrhea Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-hiv-associated-diarrhea-therapeutics-pipeline-assessment-andmarket-forecasts-135195 Scope The report provides information on the key drivers and challenges of the HIV-Associated Diarrhea Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) HIVEmail ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Associated Diarrhea Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries HIV-Associated Diarrhea Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the HIV-Associated Diarrhea Therapeutics market. - Analysis of key recent licensing and partnership agreements in HIV-Associated Diarrhea Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global HIVAssociated Diarrhea Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global HIV-Associated Diarrhea Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global HIV-Associated Diarrhea Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Human Immunodeficiency Virus (HIV) Associated Diarrhea - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology 2.3.1 Infective Causes of Diarrhea 2.3.2 Non-Infective Causes of Diarrhea 2.4 Clinical Presentation/Symptoms 2.5 Diagnosis 2.6 Pathophysiology 2.7 Treatment 2.7.1 Pathogen-Specific Therapy 2.7.2 Symptomatic Treatment 2.8 GlobalData Pipeline Report Guidance 3 HIV-Associated Diarrhea Therapeutics - Market Characterization 3.1 Overview 3.2 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - Global 3.3 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - Global 3.4 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - The US Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.5 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - The US 3.6 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - France 3.7 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - France 3.8 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - Germany 3.9 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - Germany 3.10 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - Italy 3.11 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - Italy 3.12 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - Spain 3.13 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - Spain 3.14 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - The UK 3.15 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - The UK 3.16 HIV-Associated Diarrhea Therapeutics Market Size (2006 - 2011) - Japan 3.17 HIV-Associated Diarrhea Therapeutics Market Forecast (2011 - 2019) - Japan 3.18 Drivers and Barriers for the HIV-Associated Diarrhea Therapeutics Market 3.18.1 Drivers for the HIV-Associated Diarrhea Therapeutics Market 3.18.2 Barriers for the HIV-Associated Diarrhea Therapeutics Market 3.19 Opportunity and Unmet Need 3.20 Key Takeaway 4 HIV-Associated Diarrhea Therapeutics Market - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles of the Major Marketed Products in the HIV-Associated Diarrhea Therapeutics Market 4.3.1 Paromomycin (Humatin) 4.3.2 Trimethoprim-sulfamethoxazole (Septra) 4.3.3 Metronidazole (Flagyl) 4.3.4 Diphenoxylate/Atropine (Lomotil) 4.3.5 Loperamide (Imodium) 4.4 Key Takeaway 5 HIV-Associated Diarrhea Therapeutics Market - Pipeline Assessment 5.1 Overview 5.1.1 HIV-Associated Diarrhea Therapeutics - Regulatory Filing and Phase III Clinical Pipeline 5.1.2 HIV-Associated Diarrhea Therapeutics - Phase II Clinical Pipeline 5.2 HIV-Associated Diarrhea Therapeutics Market - Pipeline Assessment by Mechanism of Action 5.3 HIV-Associated Diarrhea Therapeutics Market - Technology Trends Analytical Framework 5.4 HIV-Associated Diarrhea Therapeutics Market - Pipeline Assessment by Clinical Phase of Development 5.5 HIV-Associated Diarrhea Therapeutics - Promising Drugs under Clinical Development Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
5.6 Molecule Profile for Promising Drugs under Clinical Development 5.6.1 Crofelemer 5.7 Key Takeaway 6 HIV-Associated Diarrhea Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country 6.2 Clinical Trials by Phase of Clinical Development 6.3 Clinical Trials by Trial Status 6.4 Prominent and Overall Sponsors 6.5 Brief Profiles of Top 10 Companies Participating in Clinical Trials 7 HIV-Associated Diarrhea Therapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Future Market Competition Scenario 8 HIV-Associated Diarrhea Therapeutics - Future Players 8.1 Introduction 8.1.1 Napo Pharmaceuticals 9 HIV-Associated Diarrhea Therapeutics Market - Appendix 9.1 Market Definition 9.2 Abbreviations 9.3 Methodology 9.3.1 Coverage 9.3.2 Secondary Research 9.3.3 Forecasting 9.3.4 Primary Research 9.3.5 Expert Panel Validation 9.4 Contact Us 9.5 Disclaimer 9.6 Bibliography
List Of Tables Table 1: HIV-Associated Diarrhea Therapeutics Market, Global, Revenues ($m), 2006 - 2011 Table 2: HIV-Associated Diarrhea Therapeutics Market, Global, Market Forecasts ($m), 2011 2019 Table 3: HIV-Associated Diarrhea Therapeutics Market, The US, Revenue ($m), 2006 - 2011 Table 4: HIV-Associated Diarrhea Therapeutics Market, The US, Market Forecasts ($m), 2011 2019 Table 5: HIV-Associated Diarrhea Therapeutics Market, France, Revenue ($m), 2006 - 2011 Table 6: HIV-Associated Diarrhea Therapeutics Market, France, Market Forecast ($m), 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2019 Table 7: HIV-Associated Diarrhea Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Table 8: HIV-Associated Diarrhea Therapeutics Market, Germany, Market Forecast ($m), 2011 2019 Table 9: HIV-Associated Diarrhea Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Table 10: HIV-Associated Diarrhea Therapeutics Market, Italy, Market Forecast ($m), 2011 2019 Table 11: HIV-Associated Diarrhea Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Table 12: HIV-Associated Diarrhea Therapeutics Market, Spain, Market Forecast ($m), 2011 2019 Table 13: HIV-Associated Diarrhea Therapeutics Market, The UK, Revenue ($m), 2006 - 2011 Table 14: HIV-Associated Diarrhea Therapeutics Market, The UK, Market Forecast ($m), 2011 2019 Table 15: HIV-Associated Diarrhea Therapeutics Market, Japan, Revenue ($m), 2006 - 2011 Table 16: HIV-Associated Diarrhea Therapeutics Market, Japan, Market Forecast ($m), 2011 2019 Table 17: HIV-Associated Diarrhea Therapeutics Market - Phase III Clinical Pipeline, 2011 Table 18: HIV-Associated Diarrhea Therapeutics Market - Phase II Clinical Pipeline, 2011 Table 19: HIV-Associated Diarrhea Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2011 Table 20: HIV-Associated Diarrhea Therapeutics - Most Promising Drugs under Clinical Development, 2011 Table 21: HIV-Associated Diarrhea Therapeutics Market, Global, Clinical Trials, 2011 Table 22: HIV-Associated Diarrhea Therapeutics Market, Global, Clinical Trials by Phase, 2011 Table 23: HIV-Associated Diarrhea Therapeutics Market, Global, Clinical Trials by Status of Development, 2011 Table 24: HIV-Associated Diarrhea Therapeutics Market, Global, Sponsors, 2011 Table 25: HIV-Associated Diarrhea Therapeutics Market, Global, Companies by Phase, 2011
List Of Figures Figure 1: Approach to Acute Diarrhea in HIV-Positive Patients Figure 2: HIV-Associated Diarrhea Therapeutics Market, Global, Revenues ($m), 2006 - 2011 Figure 3: HIV-Associated Diarrhea Therapeutics Market, Global, Market Forecast ($m), 2011 2019 Figure 4: HIV-Associated Diarrhea Therapeutics Market, The US, Revenue ($m), 2006 - 2011 Figure 5: HIV-Associated Diarrhea Therapeutics Market, The US, Market Forecasts ($m), 2011 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 6: HIV-Associated Diarrhea Therapeutics Market, France, Revenue ($m), 2006 - 2011 Figure 7: HIV-Associated Diarrhea Therapeutics Market, France, Market Forecast ($m), 2011 2019 Figure 8: HIV-Associated Diarrhea Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Figure 9: HIV-Associated Diarrhea Therapeutics Market, Germany, Market Forecast ($m), 2011 2019 Figure 10: HIV-Associated Diarrhea Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Figure 11: HIV-Associated Diarrhea Therapeutics Market, Italy, Market Forecast ($m), 2011 2019 Figure 12: HIV-Associated Diarrhea Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Figure 13: HIV-Associated Diarrhea Therapeutics Market, Spain, Market Forecast ($m), 2011 2019 Figure 14: HIV-Associated Diarrhea Therapeutics Market, The UK, Revenue ($m), 2006 - 2011 Figure 15: HIV-Associated Diarrhea Therapeutics Market, The UK, Market Forecast ($m), 2011 2019 Figure 16: HIV-Associated Diarrhea Therapeutics Market, Japan, Revenue ($m), 2006 - 2011 Figure 17: HIV-Associated Diarrhea Therapeutics Market, Japan, Market Forecast ($m), 2011 2019 Figure 18: Opportunity and Unmet Need in the HIV-Associated Diarrhea Therapeutics Market Antiprotozoal Treatment Figure 19: Opportunity and Unmet Need in the HIV-Associated Diarrhea Therapeutics Market Symptomatic Treatment Figure 20: Strategic Competitor Assessment of the Marketed Products for HIV-Associated Diarrhea, 2011 Figure 21: Technology Trends Analytic Framework of the HIV-associated diarrhea Pipeline, 2011 Figure 22: Technology Trends Analytic Framework of the HIV-associated diarrhea Pipeline Description, 2011 Figure 23: HIV-associated diarrhea Pipeline by Phase of Clinical Development, 2011 Figure 24: Mechanism Of Action: Crofelemer Figure 25: HIV-Associated Diarrhea Therapeutics Market, Global, Clinical Trials by Phase, 2011 Figure 26: HIV-Associated Diarrhea Therapeutics Market, Global, Clinical Trials by Stage of Development, 2011 Figure 27: HIV-Associated Diarrhea Therapeutics Market, Global, Prominent Sponsors, 2011 Figure 28: HIV-Associated Diarrhea Therapeutics Market, Global, Overall Sponsors, 2011 Figure 29: HIV-Associated Diarrhea Therapeutics Market, Global, Companies by Phase, 2011 Figure 30: HIV-Associated Diarrhea Therapeutics Market, Drivers and Restraints, 2011 Figure 31: Implications for Future Market Competition in the HIV-Associated Diarrhea Therapeutics Market, 2011 Figure 32: GlobalData Market Forecasting Model Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018 Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to 2019 Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on HIV-Associated Diarrhea Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-hiv-associateddiarrhea-therapeutics-pipeline-assessment-and-market-forecasts-135195
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/